Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24823026 | 0.86 | ALOX5AP (0.31) | — | |
| SCHEMBL24823948 | 0.80 | AOC3 (0.32) | — | |
| SCHEMBL24824803 | 0.76 | TLR8 (0.38) | CYP11B1CYP11B2 | |
| SCHEMBL24823950 | 0.76 | CHRM2 (0.35) | — | |
| SCHEMBL24823005 | 0.74 | CYP11B1 (0.39) | CYP11B1CYP11B2 | |
| SCHEMBL24823462 | 0.70 | MAOA (0.33) | — | |
| SCHEMBL24823464 | 0.68 | NLRP3 (0.33) | CYP11B1CYP11B2 | |
| SCHEMBL24824796 | 0.68 | PIK3CA (0.33) | CYP11B2 | |
| SCHEMBL24775869 | 0.65 | AOC3 (0.33) | — | |
| SCHEMBL22306768 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411384-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411384-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | TYK2, JAK2, STAT3 | CYP11B1 573/4885CYP11B2 321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.